Speakers

Angela Scott

COO & Founder

TC Biopharm

Aviad Pato

Head of NK Research

Gamida Cell

Bertie MacArthur

Sales Manager

Beacon Targeted Therapeutics

Dan Kemp

CEO

Wugen

Donald Shaffer

Head of Precision Cytokines & Cell Therapies

Sanofi

Evren Alici

Group Leader, Associate Professor

Karolinska Institutet

Hans van der Vliet

CSO

Lava Therapeutics

Joachim Koch

VP of Translational Biology

Affimed

Jonathan Fisher

Group Leader

University College London

Kai Pinkernell

CMO

Glycostem Therapeutics B.V.

Kate Rochlin

COO

IN8bio

Katharina Filarsky

Head of Assays 3 in Biologics Research

Bayer AG

Lulu Chu

Associate Director, Cell Therapy Clinical Pharmacology & Modeling

Takeda

Marc van Dijk

CSO

MiNK Therapeutics

Mark Lowdell

CSO

INmune Bio, Inc.

Marta Barisa

Senior Fellow & Scientific Project Manager

University College London

Michael Leek

Executive Chairman & Founder

TC Biopharm

Michael Uhlin

Professor, Head of Development & IT, Department of Clinical Immunology

Karolinska Institutet & Karolinska University Hospital

Mini Bharathan

VP, Development & Translational Medicine

Arovella

Namir Hassan

CEO

Zelluna Immunotherapy AS

Niklas Björkström

Associate Professor, MD PhD

Karolinska Institutet

Nina Möker

Scientific Director Allogeneic Immunotherapy

Miltenyi Biotec

Rizwan Romee

Associate Professor of Medicine

Dana-Farber Cancer Institute

Robert Igarashi

Head of Discovery & Pre-Clinical Development

Kiadis, a Sanofi Company

Sharon Longhurst

VP of Development

Gadeta

Volker Huppert

CDO

Glycostem Therapeutics B.V.